Skip to Content
MilliporeSigma
Search Within
Document Type

637-39-8

Applied Filters:
Keyword:'637-39-8'
Showing 1-22 of 22 results for "637-39-8" within Technical Documents
Data Sheet - G0792
The Cytokine Handbook, 3rd Edition, Thomson, A.W., ed., Academic Press (San Diego, Ca, 1998), pp. 637-670. 4. Callard, R., and Gearing, A., The Cytokine Facts Book. Academic Press (New York
Anti-Crk-L antibody produced in rabbit (C0978)
ten Hoeve, J., et al., Oncogene, 8, 2469 (1993). 6. Sattler, M., and Salgia, R., Leukemia, 12 637 (1998). 7. Sattler, M., et al., J. Biol. Chem., 272 14320 (1997). 8. Sattler, M., et al., J. Biol.
XP725 Antibody Number-Lot Number 071M4826
26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3 9 10 11 12 33 34 35 36 57 58 59 60 81
TB095 pET-30a-c(+) Vector Map
4479 BslI 26 BsmI 2 4363 4440 BsmAI 6 873 1278 1404 1791 2918 4495 BsmBI 3 1791 2918 4495 BsmFI 4 637 2178 2548 5395 BsoFI 43 Bsp24I 10 466 498 1017 1049 1319 1351 3770 3802 3948 3980 Bsp1286I 12 BspEI
App. Note Detection of non-endotoxin pyrogens by MAT
in infection and immunity. Immunity 34, 637-650. 5. Henderson, B. and Wilson, M. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8, 269-282. 6. Takeuchi, O. et al. Cutting
Exploring the RNA world: An introduction to genome-wide analysis of RNA-protein interactions using RNA-binding protein immunoprecipitation (RIP)
The power of the 3’ UTR: translational control and development. Nat Rev Genet 4: 626-637. 4. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N (2009) Translational control of
Exploring the RNA world: An introduction to genome-wide analysis of RNA-protein interactions using RNA-binding protein immunoprecipitation (RIP)
The power of the 3’ UTR: translational control and development. Nat Rev Genet 4: 626-637. 4. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N (2009) Translational control of
White Paper Monocyte Activation Test
infection and immunity. Immunity 34, 637-650. 7. Henderson, B. and Wilson, M. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8, 269-282. 8. Takeuchi, O. et al. Cutting edge:
Monocyte Activation Test (MAT) White paper
infection and immunity. Immunity 34, 637-650. 7. Henderson, B. and Wilson, M. 1996. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 8, 269-282. 8. Takeuchi, O. et al. Cutting edge:
Shaping Epigenetics Discovery - Epigenetics Product Selection Brochure
1148-1107-RC http://www.millipore.com/catalogue/item/07-637?cid=BIOS-S-EPDF-1148-1107-RC http://www.millipore.com/catalogue/item/07-637?cid=BIOS-S-EPDF-1148-1107-RC http://www.millipore.com/catalogue
Protein Depletion for Plasma and Serum Proteomic Analysis
on immobilized Cibacron Blue F3-GA. Mechanism of the mo- lecular interaction. Biochem. J. 1982, 203:637-641. 116. Kubo K, Honda M, Imoto M, Morishima Y: Capillary zone elec- trophoresis of albumin-depleted
XP725 Antibody List Lot 129K4830
NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1 y n/d n/d 76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d 79 BTK, C-Terminal B0811
XP725 Antibody List Lot 129K4831
NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1 y n/d n/d 76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d 79 BTK, C-Terminal B0811
XP725 Antibody List Lot 089K4791
NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1 y n/d n/d 76 BNIP3 B7931 664 BNIP3 M NP_004043.2 y n/d n/d 79 BTK, C-Terminal B0811
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
to 35% A , 212 μL/min, 0.6 – 3 min, 35% A, 212 μL/min to 637 μL/min, 3.0 - 3.1 min, 35% A to 55% A, 637 μL/min, 3.1 – 8 min, 55% A, 637 μL/min
Material Matters Volume 1 Number 3 - Deposition of Ceramic and Hybrid Materials
st s N 1S Component Ratio 0 1 2 3 4 5 6 0 2 4 6 8 Fe content (at %) R at io ( 39 8e
XP725 Antibody List
-xL B9429 598, 24888, 12048 Bcl2l1,BCL2L1 NP_612815.1,NP_113723.2,NP_033873.3 M y y y 69 BID B4305 637 BID NP_932071.1 P y n/d n/d 70 BID B3183 12122 Bid NP_031570.2 P n/d y n/d 71 Bim B7929 10018, 12125
XP725 Antibody List 013M4793
-xL B9429 598, 24888, 12048 Bcl2l1,BCL2L1 NP_612815.1,NP_113723.2,NP_033873.3 M y y y 69 BID B4305 637 BID NP_932071.1 P y n/d n/d 70 BID B3183 12122 Bid NP_031570.2 P n/d y n/d 71 Bim B7929 10018, 12125
List of Antibodies
P y n/d n/d 634 RALAR R8529 M y y y 635 Ran R4777 M y y n/d 636 PIASy P0104 M y n/d n/d 637 RAP1 R8154 M y n/d n/d 638 RbAp48/RbAp46 R3779
XP725 Worksheet for Lot Number 071M4826
GRP94 G4420 631 4 2 1 7 hABH1 A8103 632 4 2 1 8 hABH1 A8103 633 4 2 2 1 hABH2 A8228 634 4 2 2 2 hABH2 A8228 635 4 2 2 3 hABH3 A8353 636 4 2 2 4 hABH3 A8353 637 4 2
Halal Certificate
EUGENOL 98%, FCC, FG W246700 A29021 HC-24SIAP63 636. EUGENOL, NATURAL W246719 C37178 HC-24SI8K13 637. Eugenyl Acetate W246905 C32919 HC-24SITE68 638. EVENING PRIMROSE OIL, CERTIFIED ORGANIC (NOP) W530165
Halal Certificate
EUGENOL 98%, FCC, FG W246700 A29021 HC-22SI3Z61 636. EUGENOL, NATURAL W246719 C37178 HC-22SI5W11 637. Eugenyl Acetate W246905 C32919 HC-22SIB166 638. EVENING PRIMROSE OIL, CERTIFIED ORGANIC (NOP) W530165